Shonan Beauty Clinic Launches "SBC MEDISPA PDRN®", an Oral Skin Cultivation Supplement for Inner Skin Concerns

Shonan Beauty Clinic, which receives management support from SBC Medical Group Holdings (Location: California, USA; CEO: Yoshiyuki Aikawa), has begun selling its original supplement "SBC MEDISPA PDRN®" on its official online store starting today, July 6, 2026 (Mon). This supplement contains "PDRN® (Salmon Polydesoxyribonucleotide)※", a food ingredient equivalent to PN (polynucleotide), the main component of the skin cultivation injection "Rejuran". The supplement is also sold at each Shonan Beauty Clinic location as an inner care product to maintain healthy skin, including hydration and firmness/elasticity.

※PDRN® is a registered trademark of Pharmaresearch Co., Ltd.

In recent years, the number of people suffering from dry skin has been increasing, partly due to climate change. According to the "@cosme Best Cosmetics Awards 2026 First Half New Best Cosmetics" announced by istyle Inc., the frequency of keywords related to "dryness" in @cosme reviews reached its highest level in the past five years. It was also revealed that 9 out of the top 10 products overall highlighted moisturizing as their key selling point, indicating a growing interest in moisturizing care to protect the skin from dryness.

※Source: https://www.istyle.co.jp/news/press/2026/05/0520-bc.html

Amidst this trend, the field of cosmetic medicine is seeing increased interest in "skin cultivation" treatments that aim to improve skin quality itself, rather than just moisturizing the skin's surface, by focusing on the skin's natural regenerative power. In particular, skin cultivation injections like Rejuran are gaining attention for their ability to deliver cosmetic ingredients directly to the skin, promoting the production of collagen and elastin, which are said to decrease from the late twenties, thereby maintaining firmness, radiance, and moisture, and fundamentally addressing skin concerns such as pores and fine wrinkles.

Furthermore, "edible skincare" products such as jelly sticks containing cosmetic ingredients are becoming popular, particularly in beauty-conscious countries like South Korea, and interest in inner care through oral intake is also growing. Skincare is expanding beyond daily care with cosmetics to a multifaceted approach that combines skin cultivation treatments from cosmetic medicine with inner care.

In response to this growing demand, Shonan Beauty Clinic decided to develop and sell the supplement "SBC MEDISPA PDRN®" to condition the skin from within and support hydration, firmness, and elasticity. The main ingredient, PDRN® (Salmon Polydesoxyribonucleotide), is a tissue regenerative material derived from marine resources (salmon). Salmon-derived DNA is very similar to human base composition and has excellent biocompatibility, and is known as a material that supports the skin's natural self-regeneration by promoting tissue repair, collagen and elastin production, and reducing inflammation. PN (polynucleotide), the main component of the skin cultivation injection "Rejuran", is a high-molecular-weight, high-purity component of this PDRN® for injectable formulations. "PDRN®" is a registered trademark of Pharmaresearch Co., Ltd., and only SBC Medical Group has been granted permission to use this trademark worldwide.

"SBC MEDISPA PDRN®" can be used as a home care product in conjunction with skin cultivation injections such as Rejuran, Juvelook, Jalupro, and Profhilo, realizing a new skin cultivation habit that combines skin cultivation treatment and inner care.

※For information on Shonan Beauty Clinic's skin cultivation injections, please click here.

Product Overview

Product Name: SBC MEDISPA PDRN®

Contents: 90 tablets

Recommended Daily Intake: 3-6 tablets

Main Ingredient: PDRN® raw material (1g per 6 tablets)

Country of Origin: Japan

Price: 3,996 yen (tax included)

Sales Channels:

・Shonan Beauty Clinic Official Online Store: https://sbc-store.com/shop

・Each Shonan Beauty Clinic location

SBC Medical Group Holdings

SBC Medical Group Holdings is a Medical Services Organization that provides management support to medical institutions both domestically and internationally across a wide range of medical fields, including advanced cosmetic medicine, dermatology, orthopedic surgery, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The group operates diverse clinic brands and is expanding globally into medical tourism and into the United States and Asia. The company was listed on the US NASDAQ market in September 2024 and was selected for the US stock index "Russell 3000" in June 2025. We will continue to promote the provision of reliable medical services and network expansion to achieve our group purpose of "Contributing to the improvement of happiness for people worldwide through medical innovation."

English Name: SBC Medical Group Holdings Incorporated

Listed Market: NASDAQ Global Market

Ticker Symbol (US Securities Code): SBC

Location: 200 Spectrum Center Drive Suite 300 Irvine, CA 92618 USA

CEO: Yoshiyuki Aikawa

Business: Management support for medical institutions (cosmetic medicine, dermatology, orthopedic surgery, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), ophthalmology, etc.)

Official Website: https://sbc-holdings.com

Official LinkedIn Page: https://www.linkedin.com/company/sbc-medical-group-holdings-inc

Shonan Beauty Clinic: https://www.s-b-c.net

【Contact Information】

SBC Medical Group Holdings

Public Relations Department: Murakami Email: [email protected]